These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 365478)

  • 1. Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness.
    Lebovitz HE; Feinglos MN
    Diabetes Care; 1978; 1(3):189-98. PubMed ID: 365478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 3. An appraisal of the mechanism of action of the sulphonylurea drugs.
    Martin FI
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:31-6. PubMed ID: 4949233
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve].
    Laviada E; Camara M
    Prensa Med Mex; 1973; 38(7):297-302. PubMed ID: 4596814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular basis of oral hypoglycemic sulfonylurea action].
    Owecki M; Horst-Sikorska W; Sowiński J
    Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of the sulfonylurea drugs.
    Blumenthal SA; Moses AM
    Compr Ther; 1976 Jul; 2(2):53-8. PubMed ID: 954381
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonylureas: background and development of the field.
    Levine R
    Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfonylurea drugs and insulin-independent diabetes mellitus.
    Lebovitz HE; Feinglos MN
    Compr Ther; 1979 Apr; 5(4):65-71. PubMed ID: 445991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral hypoglycemic agents.
    Boyden T; Bressler R
    Adv Intern Med; 1979; 24():53-70. PubMed ID: 371368
    [No Abstract]   [Full Text] [Related]  

  • 12. Glibenclamide: a review.
    Drugs; 1971; 1(2):116-40. PubMed ID: 5004340
    [No Abstract]   [Full Text] [Related]  

  • 13. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-pharmacological studies on the duration of action of the oral antidiabetic drug glisoxepide (author's transl)].
    Gutsche H; Losert W
    Arzneimittelforschung; 1977; 27(9):1719-26. PubMed ID: 336058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modern treatment of diabetes mellitus with sulfonylurea compounds].
    Haller H; Hanefeld M; Leonhardt W
    Z Arztl Fortbild (Jena); 1979 May; 73(10):482-7. PubMed ID: 158261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of diabetes mellitus with glibornurid].
    Vignati E; Liuzzi A; Chiodini PG
    Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with phenformin in combination with insulin or oral antidiabetic drugs in ambulatory diabetic patients].
    Stratmann FW
    Med Welt; 1976 Feb; 27(6):273-6. PubMed ID: 768703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dialysability of sulfonylurea compounds].
    Herrmann M; Kuhlmann H
    Med Welt; 1978 Sep; 29(37):1453-4. PubMed ID: 692336
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives].
    Kaniak J; Kotschy M; Kurzawska M; Paczyńska D
    Pol Tyg Lek; 1978 Jul; 33(27):1065-8. PubMed ID: 693380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Daily profile of the blood level of sulfonylurea and metabolic parameters in adult diabetics under monotherapy with various sulfonylurea compounds and comparable metabolic adjustment].
    Happ J; Nest E; Fröhlich A; Schöffling K; Beyer J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():776-9. PubMed ID: 142395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.